Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid Carcinoma

医学 病态的 甲状腺癌 持久性(不连续性) 疾病 肿瘤科 甲状腺癌 癌 内科学 甲状腺 岩土工程 工程类
作者
Simone De Leo,Valeria Bottici,Gabriella Pellegriti,Marco Russo,Caterina Mian,Federica Vianello,Barbara Puligheddu,Gerdi Tuli,Rita Ortolano,Maria Grazia Castagna,Carlotta Pozza,Małgorzata Waśniewska,Manlio Cabria,Vincenzo Rochira,Giulia Brigante,Francesco Felicetti,Maria Cristina Vigone,Maria Chiara Zatelli,Gerardo Esposito,Alessia Dolci
出处
期刊:Thyroid [Mary Ann Liebert, Inc.]
卷期号:35 (9): 1013-1023 被引量:1
标识
DOI:10.1177/10507256251363978
摘要

Background: Differentiated thyroid carcinoma (DTC) in pediatric patients has specific clinical, pathological, and molecular characteristics, making its management different from that of adults. Our study aimed to evaluate the outcome and factors associated with persistent disease in a large cohort of pediatric patients. Methods: We performed a multicenter retrospective cohort study, including patients aged ≤18 years, diagnosed with a DTC, since January 2000. Both biochemical (BIR) and structural (SIR) incomplete responses were evaluated. Results: We included 538 patients, 401/538 (74.5%) females, with a median age of 15 years (interquartile range [IQR] 13-17 years). Papillary thyroid cancer was the most prevalent histotype and 277/530 (52.3%) had lymph node metastases at diagnosis. Vascular invasion and gross extrathyroidal extension (ETE) were reported in 133/326 (40.8%) and 91/533 (17.1%) of patients, respectively. T4 tumors represented 5% of the entire cohort. Radioactive iodine treatment (RAIT) was administered to 493/533 (92.5%) patients, and among them 138/493 (28%) received more than one RAIT cycle. After a median follow-up of 85 months (IQR 42-126 months), 414/538 patients (77%) had no evidence of disease and 124/538 patients (23.0%) a disease persistence: BIR in 68/538 patients (12.6%) and SIR in 56/538 patients (10.4%). In a multivariable analysis, the features significantly associated with persistent disease (BIR or SIR) were gross ETE (odds ratio [OR] 2.81, confidence interval [CI] 1.49-5.32, p = 0.0015) and lymph node uptake at whole-body scan (WBS) after the first RAIT (OR 3.31, CI 1.77-6.19, p = 0.0002). Multivariable analysis showed that the features significantly associated with SIR were T4 tumor (OR 4.3, CI 1.38-13.44, p = 0.01) and lymph node uptake at WBS after the first RAIT (OR 3.39, CI 1.5-7.67, p = 0.003). Conclusions: Our study of a very large series of pediatric DTC with long follow-up provides valuable insights into the clinical and pathological features associated with disease persistence. We identified T4 tumor, lymph node uptake on WBS, and gross ETE as independent factors associated with persistent disease. These findings emphasize the importance of careful risk stratification in pediatric DTC, allowing for more individualized treatment approaches.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
北风北风发布了新的文献求助10
刚刚
喜悦妙柏完成签到,获得积分10
刚刚
大模型的应助被落日晚风采纳,获得10
刚刚
大方元风发布了新的文献求助10
1秒前
2秒前
cherish完成签到,获得积分10
2秒前
逢考必过发布了新的文献求助10
2秒前
Lu发布了新的文献求助10
3秒前
淡淡听枫发布了新的文献求助30
3秒前
4秒前
星辰大海的应助被红莲墨生采纳,获得10
4秒前
貝壳完成签到 ,获得积分10
4秒前
chc完成签到,获得积分10
5秒前
369ninja发布了新的文献求助10
5秒前
5秒前
orixero的应助被坚定的采波采纳,获得10
5秒前
传奇3的应助被周周周采纳,获得10
7秒前
baihehuakai发布了新的文献求助10
8秒前
mouse发布了新的文献求助10
8秒前
9秒前
10秒前
10秒前
11秒前
11秒前
Jay完成签到,获得积分10
12秒前
12秒前
暮色将至发布了新的文献求助10
13秒前
13秒前
13秒前
ding的应助被mate采纳,获得10
14秒前
14秒前
15秒前
Endeavor发布了新的文献求助10
15秒前
自由不惜发布了新的文献求助10
15秒前
红莲墨生发布了新的文献求助10
16秒前
anna发布了新的文献求助50
16秒前
包容清炎发布了新的文献求助10
16秒前
研究啥发布了新的文献求助10
17秒前
amia发布了新的文献求助10
17秒前
可爱的函函的应助被Lu采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184267
求助须知:如何正确求助?哪些是违规求助? 9573323
关于积分的说明 21830790
捐赠科研通 7781314
什么是DOI,文献DOI怎么找? 3434307
关于科研通互助平台的介绍 2558389
邀请新用户注册赠送积分活动 2480817